Moderna Stock No-Brainer After FDA Win: Buy or Not?
A recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
Get concise guidance on balancing a budget amid surprises, including flexible categories and a small emergency cushion.
25,157 articlesA recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
More than 1,700 UK investors filed a High Court group claim against Binance and Changpeng Zhao, alleging sales of hig...
The Craig Tann Group in Las Vegas posted nearly $486 million in 2025 sales, earning No. 10 in national sales volume a...
Trump allies are renewing efforts to reshape the Federal Reserve after a Supreme Court decision, targeting governors ...
AI-driven datacenters are pushing power demands higher, forcing a rethink of power distribution. Analysts flag musash...
AI-powered analytics are accelerating real-time decisions in mortgage lending. This report explains how business inte...
Beazer Homes faces a pivotal moment as Dream Finders increases its cash bid to $32 per share, intensifying the beazer...
A federal judge denied the FTC’s request for a partial summary judgment in the Zillow-Redfin rental listings antitrus...
Hydrogen names tumble after a monster 2026 run, led by FuelCell Energy, Bloom Energy, and Plug Power. The market back...
ASML, Europe’s largest semiconductor equipment maker, is poised to report second-quarter results as AI-driven demand ...
A famous AI investor argues the economics of AI deployment could shift cash flow toward infrastructure vendors like N...
When IBM hit a wall and the Dow faced pressure, Goldman Sachs stepped in as a key liquidity player, helping stabilize...